Results 151 to 160 of about 3,388,278 (296)

Circulating microRNA signatures of cachexia and cancer in Canis familiaris as a comparative oncology model for human disease

Molecular Oncology, EarlyView.
Circulating microRNAs as biomarkers of cachexia and sex‐specific cancer in senior dogs. In 25 client‐owned dogs, four circulating miRNAs (miR‐15a, miR‐15b, miR‐16, miR‐140) were downregulated in cachexia, with miR‐16 the strongest individual biomarker (AUC = 0.899).
Soon‐Seok Park, Kyongman An, Gyeonghwa Kim, Soo‐Nyun Choi, Hong‐Ki Lee, Keun Hur, Kyu‐Shik Jeong   +6 more
wiley   +1 more source

Leica RTC360

, 2020
" Leica RTC360 Solution de capture de la réalité 3D...
Consortium 3D SHS Team
core  

CEACAM1 participation in breast cancer progression

Molecular Oncology, EarlyView.
In invasive breast cancer (BC), CEACAM1 shifts from an apical to a uniform membranous/cytoplasmic pattern, or is lost, as tumors dedifferentiate, inversely tracking the Ki‐67 proliferative index. In MCF‐7 cells, only CEACAM1‐4L suppresses proliferation, repressing cell cycle and growth factor genes.
Mykola Lyndin, Irina Kube‐Golovin, Anatolii Romaniuk, Gunther Wennemuth   +3 more
wiley   +1 more source

3DF ZEPHYR

, 2020
"…software solution by 3Dflow to automatically deal with any 3D reconstruction and scanning…
Consortium 3D SHS Team
core  

Respecting Historical Spatial Integrity: Building a Historical 3D Florence and Avoiding the Video Game

Disegnare con, 2018
This article explores the process by which the Digitally Encoded Census Information and Mapping Archive (DECIMA) endeavoured to create a complete interactive 3D urban map of sixteenth-century Florence. Originally, the project consisted of a projection of
Eric Leonard Pecile
doaj  

Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer

Molecular Oncology, EarlyView.
Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas, Barbara Karakyriakou, Patricia C. Muskus, Alyssa M. Roberts, Justin Rendleman, Alexa Warren, Hanxu Lu, Kimberly A. Birmingham, Malone K. Friedman, Abigail E. Goen, Huijuan Yang, Owen M. Wilkins, Fred W. Kolling, Eugene Demidenko, Julie M. Jorns, Brock C. Christensen, Todd W. Miller   +16 more
wiley   +1 more source

Recap

, 2020
"Reality capture and 3D scanning software....
Consortium 3D SHS Team
core  

3D Deep Learning Course

The course includes the full framework for coming up with AI processing workflows, understanding why and how 3D can extend 2D approaches, developing and testing 3D Deep Learning Models, getting quickly working models on various OS, building your own ...
Poux, Florent
core   +1 more source

Somatostatin receptor 4 (SSTR4) is a tumor suppressor in cutaneous and head & neck squamous cell carcinomas

Molecular Oncology, EarlyView.
This study identifies somatostatin receptor 4 (Sstr4) as a critical tumor suppressor against skin and head/neck cancers (HNSCC, cSCC, and BCC). The loss of Sstr4 removes a check on cell growth, causing hyperactivation of the MAPK‐ERK signaling pathway (↑).
Ali Taqvi, Tuan Khang Huynh, Adway Kadam, Zahra Kardan, Yue Yan, Amina Jamal Laham, Sampath Kumar Loganathan   +6 more
wiley   +1 more source

[Offre]Ingénieur R&D outils d'analyses 2D/3D

, 2021
"L'ingénieur R&D sera chargé d'enrichir la plateforme Aïoli de nouvelles fonctionnalités. Il travaillera d'abord à l'intégration d' un outil spécifique de segmentation qui permettra d'isoler certains composants sur des images: tableaux, fenêtres, arches,
Consortium 3D SHS Team
core